相关实验视频

Updated: May 12, 2025

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

酸通过调节肠道菌群和肠道屏障,改善了小鼠的DSS引起的慢性结肠炎

Hong-Tao Wang¹, Jia-Yi Weng¹, Issoufou Amadou²

¹School of Food Science and Technology, Jiangnan University, Wuxi, 214122, Jiangsu, China; State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, 214122, Jiangsu, China.

Microbial pathogenesis

|May 8, 2025

概括

甲酸 (LFA) 通过减少炎症,改善肠道健康和增强抗氧化剂防御,有效治疗小鼠慢性结肠炎. 这种素衍生物显示出作为炎症性肠病 (IBD) 的治疗剂的前景.

科学领域:

胃肠病学胃肠病学
免疫学免疫学免疫学
微生物组研究微生物组研究

背景情况:

炎症性肠病 (IBD) 涉及炎症,免疫失调和肠道微生物群失衡.
红素酸 (LFA) 是一种红素衍生物,具有抗氧化特性,可以调节肠道pH值.

研究的目的:

在小鼠模型中研究LFA对硫酸 (DSS) 诱导的慢性结肠炎的治疗作用.
评估LFA对氧化应激,炎症和肠道微生物群组成的影响.

主要方法:

在小鼠中使用DSS诱导慢性结肠炎.
在不同的剂量中使用LFA.
评估疾病活动,结肠损伤,氧化应激标志物 (GSH-PX,SOD),炎症标志物 (TNF-α通过TLR4/MyD88/NF-κB通路),以及肠道微生物群组成 (Akkermansia,Lachnospiraceae,SCFA).

主要成果:

治疗LFA显著改善了体重和疾病活动指数 (DAI),缓解了结肠损伤.
剂量取决于LFA增强的抗氧化酶表达 (GSH-PX,SOD).
通过调节TLR4/MyD88/NF-κB通路,LFA降低了TNF-α的表达,增加了有益细菌 (Akkermansia,Lachnospiraceae),并促进了SCFA的产生.

结论:

LFA显示出对大肠炎的显著治疗潜力.
LFA增强肠道屏障的完整性,调节炎症,并恢复肠道微生物群的平衡.
在IBD管理中,LFA可能作为一种新的治疗剂.

关键词:

我们的肠道微生物群.炎症性肠病是一种炎症性肠病.肠道屏障肠道屏障肠道屏障形酸是一种形酸.氧化应激是一种氧化应激.

更多相关视频

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

Murine Colitis Modeling using Dextran Sulfate Sodium DSS

Murine Colitis Modeling using Dextran Sulfate Sodium DSS

Published on: January 19, 2010

相关概念视频

Drugs for Treatment of Constipation-Predominant IBS

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...

Drugs for Treatment of Ulcerative Colitis in IBD

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...